Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2006 1
2007 1
2008 1
2009 2
2012 1
2013 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions.
Engen CB, Wergeland L, Skavland J, Gjertsen BT. Engen CB, et al. Among authors: wergeland l. J Clin Med. 2014 Dec 15;3(4):1466-89. doi: 10.3390/jcm3041466. J Clin Med. 2014. PMID: 26237612 Free PMC article. Review.
Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies.
Oveland E, Fladmark KE, Wergeland L, Gjertsen BT, Hovland R. Oveland E, et al. Among authors: wergeland l. Curr Pharm Biotechnol. 2006 Jun;7(3):185-98. doi: 10.2174/138920106777549696. Curr Pharm Biotechnol. 2006. PMID: 16789903 Review.
Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.
Sjøholt G, Anensen N, Wergeland L, Mc Cormack E, Bruserud Ø, Gjertsen BT. Sjøholt G, et al. Among authors: wergeland l. Curr Drug Targets. 2005 Sep;6(6):631-46. doi: 10.2174/1389450054863671. Curr Drug Targets. 2005. PMID: 16178797 Review.
Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
Silden E, Hjelle SM, Wergeland L, Sulen A, Andresen V, Bourdon JC, Micklem DR, McCormack E, Gjertsen BT. Silden E, et al. Among authors: wergeland l. PLoS One. 2013;8(2):e56276. doi: 10.1371/journal.pone.0056276. Epub 2013 Feb 11. PLoS One. 2013. PMID: 23409163 Free PMC article.
Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines.
Oveland E, Wergeland L, Hovland R, Lorens JB, Gjertsen BT, Fladmark KE. Oveland E, et al. Among authors: wergeland l. Cell Biol Toxicol. 2012 Aug;28(4):201-12. doi: 10.1007/s10565-012-9216-z. Epub 2012 Mar 16. Cell Biol Toxicol. 2012. PMID: 22422053
Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.
Oveland E, Gjertsen BT, Wergeland L, Selheim F, Fladmark KE, Hovland R. Oveland E, et al. Among authors: wergeland l. Leuk Res. 2009 Feb;33(2):276-87. doi: 10.1016/j.leukres.2008.06.029. Epub 2008 Aug 8. Leuk Res. 2009. PMID: 18691757
Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.
Bredholt T, Dimba EA, Hagland HR, Wergeland L, Skavland J, Fossan KO, Tronstad KJ, Johannessen AC, Vintermyr OK, Gjertsen BT. Bredholt T, et al. Among authors: wergeland l. Mol Cancer. 2009 Nov 13;8:101. doi: 10.1186/1476-4598-8-101. Mol Cancer. 2009. PMID: 19912650 Free PMC article.
Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT. Bruserud Ø, et al. Among authors: wergeland l. Haematologica. 2004 Apr;89(4):391-402. Haematologica. 2004. PMID: 15075072
In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A, Wergeland L, Glenjen N, Gjertsen BT, Bruserud O. Ryningen A, et al. Among authors: wergeland l. Leuk Res. 2005 Feb;29(2):185-96. doi: 10.1016/j.leukres.2004.06.008. Leuk Res. 2005. PMID: 15607368
Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
Wergeland L, Sjøholt G, Haaland I, Hovland R, Bruserud Ø, Gjertsen BT. Wergeland L, et al. Mol Cancer. 2007 May 11;6:33. doi: 10.1186/1476-4598-6-33. Mol Cancer. 2007. PMID: 17498302 Free PMC article.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback